PortViewPortView
Rapid Micro Biosystems logo

Rapid Micro Biosystems (RPID) Stock Analysis

NASDAQHealthcareMedical - Devices

$1.43-4.67%
1-year price historyRange $1.45 – $4.68
52-week range$1.43
$1.43$4.94

What Rapid Micro Biosystems does

Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications. Beyond their core product, the company also delivers essential services, including system installation, verification, expert technical training, and continuous support. Their technologies are widely applied in vital areas like environmental monitoring, water quality testing, bioburden assessment, and final sterility release evaluations. Established in 2006, the company initially traded as Genomic Profiling Systems, Inc., before rebranding to Rapid Micro Biosystems, Inc. in January 2007, and maintains its headquarters in Lowell, Massachusetts.

Key metrics

Market cap
$64.81M
P/E (TTM)
-1.28
EPS (TTM)
$-1.12
Beta
1.48
Dividend yield
0.00%
Revenue / share
$0.75
50-day avg
$1.83
200-day avg
$2.79
52-week high
$4.94
52-week low
$1.43
CEO
Robert G. Spignesi Jr.

ETFs linked to RPID

Broad-market and Healthcare sector ETFs an investor holding Rapid Micro Biosystems is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how RPID fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze RPID in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Rapid Micro Biosystems?
Rapid Micro Biosystems trades under the ticker RPID on NASDAQ.
Which exchange is RPID listed on?
RPID is listed on NASDAQ.
What sector does Rapid Micro Biosystems operate in?
Rapid Micro Biosystems is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze RPID in a portfolio?
PortView shows RPID's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.